Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
about
Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?PPAR-γ -- a possible drug target for complicated pregnanciesPPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyTherapeutic approach in the improvement of endothelial dysfunction: the current state of the art15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome.Endothelial PPAR-γ Protects Against Vascular Thrombosis by Downregulating P-Selectin ExpressionSignificanceCommonalities in the Association between PPARG and Vitamin D Related with Obesity and CarcinogenesisInflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical ExerciseCMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivoω-3 PUFA rich camelina oil by-products improve the systemic metabolism and spleen cell functions in fattening pigsCurcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signalingOpposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligandFam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesisAdipose tissue dysfunction and hypertriglyceridemia: mechanisms and management.De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.PPARgamma agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis.Tumor grade related expression of neuroglobin is negatively regulated by PPARγ and confers antioxidant activity in glioma progressionEpigenetic effects of human breast milk.Adipose tissue collagen VI in obesity.Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats.Linkage analysis of obesity phenotypes in pre- and post-menopausal women from a United States mid-western populationEnergy restriction as an antitumor target of thiazolidinediones.In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study.Bioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative peroxisome proliferator-activated receptor gamma in mouse aorta.Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?Antidiabetic effect of Sida cordata in alloxan induced diabetic ratsCausal inference in longitudinal comparative effectiveness studies with repeated measures of a continuous intermediate variable.Anti-Inflammatory and PPAR Transactivational Effects of Oleanane-Type Triterpenoid Saponins from the Roots of Pulsatilla koreanaCoordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice.Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.Identification of the lipid droplet targeting domain of the Cidea proteinTroglitazone and Δ2Troglitazone enhance adiponectin expression in monocytes/macrophages through the AMP-activated protein kinase pathway.Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α.The roots of Atractylodes japonica Koidzumi promote adipogenic differentiation via activation of the insulin signaling pathway in 3T3-L1 cells.
P2860
Q26829503-3139FABA-2DCA-4C93-9253-7909A72CDFA5Q26863678-0EB0EC9B-13BA-43A5-9CB3-986B06A76655Q27024799-178B942A-634B-4F35-87BB-CE0A0BD21FC9Q27027533-D92DEC8F-8A70-4915-B909-270B864D4117Q27316915-E741ADA9-AAFE-4063-959A-F06487C22CF0Q27342480-E1929BD7-8245-4738-A816-0180E0506443Q28070220-A95D4B11-76FD-4C26-ADC9-9EAAAFA7B407Q28076878-B1E0C99B-6EDC-47A3-966B-CCFC86EF20B2Q28540538-97F407E2-B11D-4317-A7E1-AF9A56B6FDE6Q28543700-1B33DF57-3754-4619-BB9C-DA133097CF3AQ28565783-C2C431D7-B19F-4611-A023-96884C363916Q28581020-0C596EC3-C687-4528-B45A-E75BEFB098BEQ28589295-96161455-9503-42CF-B6ED-8687208EEFC4Q30404697-FDBD71A8-A1D3-4853-A7EE-5184C875FB03Q33419872-895C1E42-869A-42EA-A974-210044AE2C04Q33520918-6C39D513-140E-44FA-8C08-ED38FE054738Q33561578-2538E6DD-3954-4497-A7EB-F9CF3AE38797Q33570511-81A63470-F462-496D-AC4B-876FD7CE1A3BQ33644457-AC230714-2F51-47E6-A430-7E2E0E7E7DE4Q33664745-279AF65C-13D4-4424-86FC-554549D01831Q33692555-CCDBA41D-C59F-4620-B5EB-8F8C2CFE7259Q33741191-AE0928E7-E9F7-4C09-9074-AB6F2A43CF0AQ33742726-98F1CF48-A2B1-4D15-BF63-7F98D2B900F4Q33744668-503D763C-CDFF-433C-A4A6-6E1CF21FC8F0Q33757779-3B376926-6EB2-47A1-BB84-E93BA98CC517Q33772466-186F0FE1-3347-4A82-87DD-34EDD3D24402Q33836877-1D517635-D51F-41AA-AE19-54DF6E521A2EQ33953983-883D6C9A-82C3-41DB-992C-BEBD9A881766Q33993986-5AEFC7A0-084F-403B-A4AB-8911A779C1C4Q34006042-434C879E-3479-4B0B-901E-71ACF52B3943Q34039797-C5420EB3-AE2A-475F-AF80-6DC9A9CF51DBQ34191246-8079B28D-9260-4320-BA50-80FF960BBD42Q34235817-18438816-69FE-43E2-AA25-333C075E2415Q34287811-8A3AD9B9-E541-4F8A-A16C-F46474A132DFQ34307484-083567F7-6808-4F26-99D4-85FFB320929AQ34316470-3B92E68E-27AB-4604-B4AC-5BAF66FFF5CEQ34330155-FC7AAB46-1F17-4F67-9FFC-5259192EA02DQ34406470-99DBD6C8-5F95-40E7-A01E-42D6943F08C0Q34412709-5E3191A5-CBFC-4A63-99EF-7B6CFDCC0F9DQ34414735-476599A6-5F48-4BA2-A036-1E3BF19A5CC3
P2860
Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Review: Peroxisome proliferato ...... lipid and glucose metabolism.
@ast
Review: Peroxisome proliferato ...... lipid and glucose metabolism.
@en
type
label
Review: Peroxisome proliferato ...... lipid and glucose metabolism.
@ast
Review: Peroxisome proliferato ...... lipid and glucose metabolism.
@en
prefLabel
Review: Peroxisome proliferato ...... lipid and glucose metabolism.
@ast
Review: Peroxisome proliferato ...... lipid and glucose metabolism.
@en
P356
P1476
Review: Peroxisome proliferato ...... lipid and glucose metabolism.
@en
P2093
Arya M Sharma
Bart Staels
P304
P356
10.1210/JC.2006-1268
P407
P577
2006-12-05T00:00:00Z